This week’s BTC-USD price recap: Following a $700 drop, BTC-USD managed to find a bottom around $4200 before entering into a 4-day long consolidation pattern. During the consolidation pattern, the price climbed $400 on decreasing volume before ultimately dropping back to $4200. So, where does this leave us and what can we expect in the […]
Distributed ledger startups Ripple and R3 have become embroiled in a new legal battle over a cryptocurrency options contract dispute.
The crypto market, especially in China, has been in a panic in these past few days, largely because of an official notice on Preventing Risks of Fundraising Through Coin Offering, jointly issued by the People’s Bank of China (PBOC), the Cyberspace Administration of China, the Ministry of Industry and Information Technology, the State Administration for […]
A new bitcoin investment fund manager has received the approval of securities regulators in Canada.
ConsenSys, an Ethereum production studio based in Brooklyn, NY, is launching a $50 million venture arm, and it has picked Kavita Gupta to run it. Gupta’s job will be to oversee the new venture and help structure deals with the startups. It is not uncommon for companies with investment capital to form their own investment […]
GreenAddress (and its reimplementation GreenBits), the Bitcoin wallet that was acquired by blockchain infrastructure company Blockstream earlier this year, is the first mobile wallet to offer Segregated Witness (SegWit) transactions. This means that GreenAddress users are among the first to benefit from lower fees and faster transaction times enabled by the long-awaited protocol upgrade. “The […]
After Labor Day weekend, many ETH-USD traders were surprised to find a 30% market drop over the course of 3 days. After an initial drop to the $330s, the ETH-USD market suffered another blow as China announced it will be banning ICOs and conducting rigorous investigations into several of the newer coins such as NEO […]
The Isle of Man is opening its doors to legally complaint ICOs.
Last week, the U.S. Food and Drug Administration (FDA) approved the gene drug Kymriah for certain types of cancer. However, Kymriah costs $475,000 for one single treatment, Bloomberg reports, which is well beyond being affordable for average patients. In the U.S., the FDA approval process itself adds billions of dollars to drug development costs, which […]
China has banned ICOs – and the country’s exchanges are quickly moving to adapt to the new reality.